about
Hyperthyroidism secondary to hysterosalpingography: an extremely rare complication: A case reportAntithyroid Drug Therapy for Graves' Disease and Implications for Recurrence.Non-Neuronal Cells in the Hypothalamic Adaptation to Metabolic SignalsThe Emerging Role of Epigenetics in Autoimmune Thyroid Diseases.Excess maternal and postnatal thyroxine alters chondrocyte numbers and the composition of the extracellular matrix of growth cartilage in rats.TSHR as a therapeutic target in Graves' disease.Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women.Switching Therapy from Intravenous Landiolol to Transdermal Bisoprolol in a Patient with Thyroid Storm Complicated by Decompensated Heart Failure and Gastrointestinal Dysfunction.A rare case of methimazole-induced cholestatic jaundice in an elderly man of Asian ethnicity with hyperthyroidism: A case report.Survey of Clinical Practice Patterns in the Management of 992 Hyperthyroid Patients in France.Predictive Value of Gene Polymorphisms on Recurrence after the Withdrawal of Antithyroid Drugs in Patients with Graves' Disease.Preoperative management in patients with Graves' disease.A patient-specific treatment model for Graves' hyperthyroidism.GLIS3 is indispensable for TSH/TSHR-dependent thyroid hormone biosynthesis and follicular cell proliferation.Hypothalamic-pituitary-thyroid (HPT) axis functioning in anxiety disorders. A systematic review.Expert consensus document: A 'diamond' approach to personalized treatment of angina.Long-term outcome of thyrotoxicosis in childhood and adolescence in the west of Scotland: the case for long-term antithyroid treatment and the importance of initial counselling.Does Surgery Without Lugol's Solution Pretreatment for Graves' Disease Increase Surgical Morbidity?Multifocal oral melanoacanthoma associated with Addison's disease and hyperthyroidism: a case report.Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy.Prediction of response to medical therapy by serum soluble (pro)renin receptor levels in Graves' disease.Flushing Disorders Associated with Gastrointestinal Symptoms: Part 2, Systemic Miscellaneous Conditions.Clinical Feasibility of Continuously Monitored Data for Heart Rate, Physical Activity, and Sleeping by Wearable Activity Trackers in Patients with Thyrotoxicosis: Protocol for a Prospective Longitudinal Observational Study.Role of Diffusion-Weighted Magnetic Resonance (MR) Imaging in Differentiation Between Graves' Disease and Painless Thyroiditis.Thyroid Functioning and Fatigue in Women With Functional Somatic Syndromes - Role of Early Life Adversity.Validity and Reliability of the Korean Version of the Hyperthyroidism Symptom Scale.Is routine measurement of TSH in hospitalized patients necessary?Elevated Serum IL-17 Expression at Cessation Associated with Graves' Disease Relapse.Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism.Prevalence and Annual Incidence of Thyroid Disease in Korea from 2006 to 2015: A Nationwide Population-Based Cohort Study.De novo coronary artery disease in graves' disease. coincidence?Thyroid Screening in Early Pregnancy: Pros and ConsNo link between season of birth and subsequent development of Graves' disease or toxic nodular goitre: a nationwide Danish register-based study
P2860
Q33167983-6B3A50C8-7E8F-4286-AE1E-769083563910Q33655557-86A8B1C6-D42A-4D5C-B123-B197885242DFQ37712631-429033CF-5C30-4F03-B00F-04F368248E9BQ37740639-B138E42D-B805-4B1E-8F01-E14D5E2EC5BBQ38867544-D32CE022-E1E0-466C-A8D9-09C20D131268Q39106190-CBA72B1D-E140-46E7-A2EE-4642BD4393BCQ40173864-287F0A0C-5CCF-4AD8-BAAB-CA2C1A8432D5Q42620049-2EAF69EF-5625-4BEB-9F14-132154E04837Q47109832-EF5AC351-8311-49FF-B718-68AD335E2936Q47114011-861B55BB-5334-43A2-933F-9CD240F5EB38Q47117259-FC92E0DA-BE4E-4E54-AC01-18028E828B8DQ47122099-F94A70DA-C3C8-4B26-9F32-A9E4BB05CF4EQ47196205-0442C6D6-B9E1-4161-855A-31E9253C94D7Q47588788-75A00208-DC0E-4779-9CEB-44973F41B663Q47730251-5FB41BA9-7372-4FD1-9D1F-2F3A96739275Q48022963-6ADB06EE-C1BE-4E09-B4D3-168CFDA8C33FQ50134683-187EBFC0-E053-4A7B-804C-293A1843E82AQ50182191-7B994A84-9E9A-4325-97E1-EF63F5C3090FQ50556459-21F05E8F-4ED2-4D57-9FC3-1017CE36F8BEQ51370817-84CF1B35-CC33-4EF3-8238-E279B4DD2EAFQ52604581-648012BA-BE91-41D9-AF1F-4299A137C531Q52719732-64AD4196-1523-43FF-89E5-7D0F5872AA5DQ53082229-18D2E740-B5C4-4C75-AD56-B7F0F541D44CQ53692400-C63B348B-929A-412A-A112-BEB387111C6AQ54963448-D0799EEC-AC29-4179-89D1-E7748DEE99DCQ54977606-B5E5D0AC-E1A6-4F39-A7CA-5338A54E23F8Q55258717-092F24F4-FF23-4F26-A8C8-4B9EFD902FCFQ55286389-829ABB95-9C1E-4074-8328-E1DA7DB9C467Q55311366-099F3F02-C71F-4546-9F26-C7420E408284Q55398278-F00D46AB-1C90-4110-B802-569605548751Q57814877-7F1CA52E-7410-4F7C-9211-1B8C84D79678Q58556141-E06357EB-183D-43D7-A2F1-05D767177F9DQ58709623-3A9E4E5D-4BDF-4019-80EF-E624D11BF71C
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Hyperthyroidism
@ast
Hyperthyroidism
@en
Hyperthyroidism.
@nl
type
label
Hyperthyroidism
@ast
Hyperthyroidism
@en
Hyperthyroidism.
@nl
prefLabel
Hyperthyroidism
@ast
Hyperthyroidism
@en
Hyperthyroidism.
@nl
P2860
P1433
P1476
Hyperthyroidism
@en
P2093
Lewis E Braverman
P2860
P304
P356
10.1016/S0140-6736(16)00278-6
P407
P577
2016-03-30T00:00:00Z